Category Archives: Competition Law

Competition Law Patent

Thoughts on Regulatory Tussles Involving CCI – III


[*Long post] Earlier posts – Thoughts on Regulatory Tussles Involving CCI – I & Thoughts on Regulatory Tussles Involving CCI – II [Continuing…..] Delhi HC judgment on Telefonaktiebolaget LM Ericsson v. Competition Commission of India and Anr Issues Is there an irreconcilable conflict between the Competition Act and Patents Act? and Is it possible to construe both the Acts harmoniously? Judgment  An inconsistency or repugnancy in statutes cannot be readily inferred and any interpretation that leads to such conflict must, as…


Read More »
Competition Law Patent

Thoughts on Regulatory Tussles Involving CCI – II


[*Long post] I shall be dealing with the Delhi HC judgment on Telefonaktiebolaget LM Ericsson v. Competition Commission of India and Anr, limited to the issue of Competition Act versus Patents Act. The idea is to simplify the judgment for the benefit of readers and present views where applicable. This is strictly an academic exercise. I shall not be dealing with the facts and other issues since the mandate is limited here. SpicyIP had already dealt with this judgment before….


Read More »
Competition Law

Thoughts on Regulatory Tussles Involving CCI – I


Introduction The world does not need any more lessons on the need for a “regulated” market so as to preclude market failures. At the same time, it is imperative to design a regulatory framework with minimum frictions amongst the regulators themselves. Having set the context, I intend to pen down my thoughts on regulatory tussles involving Competition Commission of India (CCI). In subsequent posts, I shall critically examine the Delhi High Court judgment in 2016 (Ericsson case) which dealt with…


Read More »
Competition Law Patent

TRAI Invites Comments on Patents Act, FRAND | Views on Inter Agency Co-Operation


Last week, the Telecom Regulatory Authority of India (TRAI) issued a consultation paper on promoting local telecom equipment manufacturing in India and invited comments from readers.  I believe that this is a great opportunity for all stakeholders to provide their comments to the TRAI.  The paper may be downloaded from here or by going to the TRAI site and then at publications / consultation papers. The deadline for submitting comments is 16.OCT.2017 and may be emailed to arvind[AT]trai{dot}gov{dot}in and bharatgupta{dot}[email protected]{dot}com…


Read More »
Competition Law

Competition Commission of India (or Delhi?) Seeks to Outsource Study on Healthcare Industry to Medical Professionals, Radiologists, Pharma Graduates etc.


The Competition Commission of India (CCI) recently floated a ‘Request for Proposal’ (RFP) for an agency to conduct the following study: “Situation Analysis to understand the prescription and referral pattern of Hospitals and Medical Practitioners and also the tie-ups and networking amongst various stakeholders in Health Care Sector”. The study intends to focus on different hospitals, clinics, diagnostic centres, pharmaceutical companies, pharmacists, insurance companies, third party administrators, patients, care-givers, doctors etc. and cover the following specializations: cardiology, neurology, orthopedics, ophthalmology,…


Read More »
Competition Law Drug Regulation

The CCI’s Identity Crisis and Dealing with Misplaced Criticism


The Competition Commission of India (CCI) will complete 14 years of its existence this year, having been established in 2003 (although it became fully functional only much later). Like all teenagers, the people around it can’t seem to identify its exact role in the universe. In the case of the CCI, the question is whether the institution is a part of the executive or the judiciary. This issue was raised before the Supreme Court in the case of Brahm Dutt…


Read More »
Competition Law Patent Unfair Competition

Apple v. Nokia – patent privateering – Will the CCI take suo moto notice?


Last month, Apple and Nokia announced that they were settling all pending litigation with each other. In a statement available on Apple’s website, Nokia stated, “This is a meaningful agreement between Nokia and Apple,” Maria Varsellona, Chief Legal Officer, Nokia.  It moves our relationship with Apple from being adversaries in court to business partners working for the benefit of our customers.” Apple filed the first complaint against several entities, all of whom had purchased SEPs from Nokia / or were…


Read More »
Competition Law Drug Regulation

Is Patent Enforcement Anti-competitive? Delhi HC Expresses Some Caution!


The Roche: Biocon saga over Herceptin took a dramatic new turn recently. Before getting into the details, here is a short timeline for those interested (I have not included a list of all the suits filed, for the sake of brevity). The Timeline Roche sued Biocon and Mylan before the Delhi High Court, seeking to restrain their sales of a biosimilar of Roche’s breast cancer medication, Trastuzumab. Rahul carried an analysis of that order over here and here. In this…


Read More »
Competition Law Patent

Pharma Price Control and Policy Schizophrenia – III: Make Antitrust Great Again


Over the previous posts (here and here), I outlined the current state of pharmaceutical price control, and outlined inefficiencies inherent to the existing framework. Over the course of this post, I dive deeper into the harms caused by an ineffective price control regime, and outline more optimal policies to enhance access to drugs. Price control as a boogeyman The fact that price control in the drugs market today is entirely ineffective appears to be the subject of a careful cover-up…


Read More »
Competition Law Patent

Pharma Price Control and Policy Schizophrenia – II: Cheating the consumer


Over the previous post, I summarised the events that led up to the current government’s ostensible decision to disband the National Pharmaceutical Pricing Authority and pave the way for a radical curtailment in the scope of pharmaceutical price control. While pressure groups such as the AIDAN, and other political agents (such as the Swadeshi Jagran Manch) have viewed the move as an egregious attempt to pull the rug from underneath the feet of patients, the question remains whether the DPCO was…


Read More »